VECTIBIX DIN 02308487
Status: Marketed
Holder: AMGEN CANADA INC
Available to quote
Health Canada record
| Active ingredient(s) | PANITUMUMAB 100 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Intravenous |
|---|
| Schedule | SCHEDULE D; PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | L01FE02 PANITUMUMAB |
|---|
| Original market date | 27-May-2008 |
|---|
| Current status date | 27-May-2008 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Amgen Canada Inc — licence 100048, currently licensed, last inspection rating C (2023-03-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PANITUMUMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02308509 | VECTIBIX | AMGEN CANADA INC | Solution | PANITUMUMAB 400 MG | Marketed |
| 02308495 | VECTIBIX | AMGEN CANADA INC | Solution | PANITUMUMAB 200 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 9464 | 2008-04-03 | New Drug Submission (NDS) | |
Request a quote for VECTIBIX
How to read a Canadian DIN record